Publications : Details

E6 Based Rapid Diagnostic Test for Cervical Pre-Cancer and Cancer

A pilot clinical study suggests that E6 is an appropriate biomarker for diagnosis of cervical pre-cancer and cancer in a novel oncoprotein-based rapid diagnostic assay for cervical pre-cancer and cancer. Presented at: International Papillomavirus Conference 2009, May 8, 2009; Malmo, Sweden.

Author(s): Schweizer J, Berard-Bergery M, Bisht A, et al

Corporate author(s): PATH, Arbor Vita Corporation, Johns Hopkins Bloomberg School of Public Health

Publication date: May 2009

Available materials

English

E6 Based Rapid Diagnostic Test for Cervical Pre-Cancer and Cancer (poster)

405 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also:

Health technologies > Diagnostic technologies

Reproductive health > Sexually transmitted infections

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA